Our Story

 

New vaccine technology is changing the whole industry

 

 

We are delighted to welcome you to the World Vaccine Congress.

For the past 18 years, the congress that evolved and grown tremendously into the leading vaccines congress globally, in content, speakers, attendees and networking opportunities.

Back in 2015, we introduced a successful new format which allowed for whole-sector topics, giving an opportunity for people to find out more about their specific area of research and their job-function. By running parallel niche conferences over part of the Congress, it increased the relevance of the whole event for everyone who attended.

The impact of this was to increase the quality of the speaker line-up and those who signed up to attend, as the content truly moved forward, covering the important blue-sky keynotes whilst also providing personalised content for every attendee.

In 2018, we will be continuing this format with new pre-congress workshops and new conferences in Vaccine Safety and Vaccine Logistics. We will also continue our previous conferences in Cancer Immunotherapy, Immune Profiling, Respiratory Vaccines, Emerging & Re-emerging Diseases, Clinical Trials, Vaccine Partnerships, Bioprocess & Manufacture and Veterinary Vaccines.

Throughout these sessions you will learn how cutting-edge research efforts can be integrated with pharma, biotech, academia and government to produce more and better vaccines to the market. 

With so much on show throughout these four days, we’re confident that you will walk away from this year’s congress safe in the knowledge that your time and expense were well worth it.

 

 

WORLD VACCINE CONGRESS WASHINGTON INCLUDES:

 

INFLUENZA AND RESPIRATORY

 

Find ways to improve development of universal influenza, RSV, MERS and Pneumococcal vaccines.

 

MORE

BIOPROCESSING AND MANUFACTURING

 

Optimize early formulation through to clinical manufacturing, by embracing new techniques and technologies.

 

MORE

CANCER AND IMMUNOTHERAPY

 

From new adjuvant technologies to novel immunotherapies, better understand the latest developments in the fast-evolving cancer landscape.
 

MORE

IMMUNE PROFILING

 

Discuss how profiling of the immune system using high throughput technologies can aid therapeutic design and treatment strategies in infectious and noninfectious diseases including cancer.

MORE

 

PARTNERSHIPS

 

Hear from exciting new vaccine biotechs presenting on their pipeline as well as case studies and on how best to form public-private partnerships.

MORE

CLINICAL TRIALS

 

Assess how to improve your clinical trial performance, from developing novel immunological assays to creating clinical efficacy.
 

MORE

EMERGING AND RE-EMERGING DISEASES

 

Understand the opportunities for your business in reacting to global threats like malaria, dengue and Ebola..

MORE

VETERINARY

 

From livestock to companion, gain crucial insights into the emerging infections and new technologies changing the landscape.

MORE

I've religiously attended the WVC annually nearly since inception. The WVC represents the compilation & orchestration of top global vaccine development leaders in a highly efficiently paced environment that creates individual and collective impact to further this highly impactful area of medicine.


Founder, Advanced Clinical Research

Get Involved At World Vaccine Congress Washington

 

To Sponsor Or Exhibit

Marc Rhys-Evans
marc.rhys-evans@terrapinn.com
+44 20 7827 5945

 

 

 

To Register

Tayyab Abbasi
tayyab.abbasi@terrapinn.com
+44 20 7092 1210

 

 

 

Press Relations

Karina Kusova
karina.kusova@terrapinn.com
+44 20 7092 1071